Vivos' cost-cutting initiatives also led to a $1 million or 27% year-over-year reduction in operating loss, versus the third quarter of 2023. For the nine months ended September 30, 2024 operating ...

2 Top Growth Stocks to Buy on the Dip was originally published by The Motley Fool ...

Nearly 99% of people with prediabetes and obesity or overweight who took weekly tirzepatide injections remained diabetes-free ...

The Centers for Medicare & Medicaid Services (CMS) on Nov. 1, 2024, released the calendar year (CY) 2025 Revisions to Payment Policies under ...

"This new clinical practice guideline from the AASM represents an important turning point in the treatment of RLS in adults," ...

Previously, sleep ... apnea, yes, this can be very dangerous." "There is limited evidence on the benefits of mouth taping and I would be very careful — and even talk to your health care provider ...

A doctor discusses the beauty breathing technique that could be the solution to snoring and other breathing abnormalities ...

Ever wonder what causes anxiety dreams and how to overcome them? We spoke to a sleep medicine specialist and gathered the ...

In a new study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs ...

Intervention studies have demonstrated the positive effect of glycemic control on periodontitis and vice versa, with ...

University of Sheffield spinout company, Rinri Therapeutics, a company focused on developing new treatments for hearing loss ...

In fact, more and more teens that meet certain weight and health criteria are going on GLP-1s after the FDA’s approval of ...